Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference1x1 Investor Meetings: August 8-9, 2023Location: Lotte Palace Hotel, New York, NY

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com

Vor Biopharma (NASDAQ:VOR)
過去 株価チャート
から 5 2024 まで 6 2024 Vor Biopharmaのチャートをもっと見るにはこちらをクリック
Vor Biopharma (NASDAQ:VOR)
過去 株価チャート
から 6 2023 まで 6 2024 Vor Biopharmaのチャートをもっと見るにはこちらをクリック